No Data
No Data
Does China Resources Pharmaceutical Group (HKG:3320) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Some mainland pharmaceutical stocks rose, with Sihuan Pharm (00460) up 3.85%. Institutions pointed out that drug price monitoring and governance are expected to help the industry's health.
Mainland pharmaceutical stocks have risen partially, with Sihuan Pharm (00460) up 3.85%, Haohai Biotech (06826) up 2.68%, Shanghai Pharma (02607) up 2.08%, Sinopharm (01099) up over 1%, TongrentangCM (03613) and Chinares Pharma (03320) following suit. Citic Sec pointed out that many places have launched drug price comparison platforms recently, but the bank believes that comparison does not mean price limitation. The Medical Insurance Bureau launched a special campaign of "going online stores, checking drug prices, comparing data, and cracking down on governance". The regulation of drug prices is not only about seeking low stock price, but also about eliminating price discrimination.
chinare pharma (03320.HK): KPC Pharmaceuticals, Inc. intends to acquire a 51% stake in Huaren Shenghuo for 1.791 billion yuan.
On June 11th, Glonhui reported that CR Pharma (03320.HK) announced that on June 7, 2024, the board of directors passed a resolution and approved the equity transfer agreement to be signed by CR Sanjiu (000999.SZ), a non-wholly owned subsidiary of the company, and Kunming Pharmaceutical Group (600422.SH) ("Equity Transfer Agreement"). Accordingly, CR Sanjiu will agree to sell and Kun Pharma will agree to acquire 51% equity interest of Kunming CR Sanjiu Medical & Pharmaceutical Co., Ltd. ("CR Sanjiu") for a total consideration of RMB 1.791 billion ("Proposed Internal Restructuring"). As of this announcement, CR Sanjiu is owned by CR.
Express News | China Resources Pharmaceutical - on Completion of Proposed Reorganization Expected That Co's Interest in Cr Shenghuo Will Be Diluted to 39.88%
Express News | China Resources Pharmaceutical- Kpc Will Agree to Acquire 51% Stake in Kunming China Resources Shenghuo Pharmaceutical for RMB1,791 Mln
Express News | China Resources Pharmaceutical - on 7 June Passed Approved That Unit and Kpc Pharmaceuticals Enter Into a Share Transfer Agreement
No Data